Getting radiopharmaceuticals to patients is about more than just approvals. This session evaluates the strategies needed to launch successfully and navigate global regulations with confidence.

• Comparing procedural and regulatory differences in TRP use across major global markets
• Highlighting key challenges in harmonising clinical standards, manufacturing, and approval pathways
• Discussing strategies to align stakeholders and streamline international TRP administration